Condition
Pancreas Cancer
Estimated Enrollment: 17
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: IIT2007022|2007-022
Study First Received: March 17, 2009
Last Updated: December 7, 2015
Estimated Primary Completion Date: July 2009
Primary Outcome Measures:
Progression-free Survival|Objective Response|CA 19-9 Response|Number of Participants With Adverse Events
Sponsors and Collaborators:
Georgetown University|Eli Lilly and Company
Website Link: https://ClinicalTrials.gov/show/NCT00864513
